The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First clinical (phase 1b/2a) study of iberdomide (CC-220; IBER), a CELMoD, in combination with dexamethasone (DEX) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Research & Development
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis
 
Rakesh Popat
No Relationships to Disclose
 
Jeffrey A. Zonder
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen; Prothena; Seagen; Takeda
Research Funding - Celgene (Inst)
 
Monique C. Minnema
Consulting or Advisory Role - Amgen; Janssen-Cilag; Janssen-Cilag; SERVIER; Takeda
Research Funding - Celgene
Travel, Accommodations, Expenses - Amgen; Roche
 
Jeremy Larsen
No Relationships to Disclose
 
Tuong Vi Nguyen
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Min S. Chen
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Amine Bensmaine
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Mariana Cota
No Relationships to Disclose
 
Pieter Sonneveld
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Skyline Diagnostics; Takeda